References
- Gay, F., Diquet, C., Katlama, C., Fassin, D., Turk, P., Datry, A., Danis, M. & Gentilini, M. (1991). Therapie, 46, 89–91.
- Parola, P., Ali, I., Djermakoye, F., Crassard, N., Bendavid, C., Faugere, B. & Condomines, P. (1999). Bulletin de la Société de Pathologie Exotique, 92, 317-319 (in French).
- Plowe, C. V., Doumbo, O. K., Djimde, A., Kayentao, K., Diourte, Y., Doumbo, S. N., Coulibaly, D., Thera, M., Wellems, T. E. & Diallo, D. A. (2001). American Journal of Tropical Medicine and Hygiene, 64, 242–246.
- Wongsrichanalai, C., Pickard, A. L., Wernsdorfer, W. H. & Meshnick, S. R. (2002). Lancet Infectious Diseases, 2, 209–218.
- World Health Organization (1996). Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Document WHO/MAL/96. 1077. Geneva: WHO.
- World Health Organization (2002). Monitoring Anti-malarial Drug Resistance. Document WHO/CDS/ CSR/EPH/2002.17. Geneva: WHO.